Science & technology

Study: New Therapy Repairs Damaged Cells After Heart Attack

Is the heart's inability to regenerate a protective trade-off we must first understand or a problem we should rush to fix with new therapies?

1 hour ago·Updated 31 minutes ago

Study: New Therapy Repairs Damaged Cells After Heart Attack

Story

Above: A woman holds a heart-shaped object. Image credit: Unsplash

The Facts

University of Cambridge scientists have developed an experimental mRNA therapy that reawakens heart muscle cells so they divide and help repair damage from a heart attack. Their study was published in the journal Nature Cardiovascular Research on Monday.
mirror.co.uk
The Telegraph
Nature
In mice treated after a heart attack, the therapy produced a stronger heartbeat and increased the blood pumped with each beat by about 10% compared with animals given a mock treatment. Scientists now want to test it in larger mammals and humans.
University of Cambridge
The Sun
The treatment works by injecting temporary genetic instructions that activate two proteins in heart cells, Myc and Cyclin T1, which control cell division and prompt dormant cells to divide and replace damaged tissue.
Fox 21 online
Bioengineer.org
Because the mRNA signal is short-lived and localized, scientists said there was no risk of excessive cell growth and that they saw no adverse effects in the mice, whose improved heart function persisted at 28 days and 12 weeks.
University of Cambridge
The Telegraph
An adult human heart can lose up to 1 billion muscle cells — 25% to 33% — after a heart attack, and those cells are never replaced. About 200,000 people in the United Kingdom are diagnosed with heart failure each year.
EurekAlert!
The Sun
British Heart Foundation

Sources Split

LEFT

CENTER

RIGHT

ESTAB
CRIT

CENTER

PRO
ESTAB

The Spin

Narrative A

The heart's inability to regenerate is not simply a biological failure but a protective adaptation. By restricting signals to the nucleus, heart cells protect themselves from damage caused by high blood pressure. Restoring regeneration without understanding this trade-off could create new risks. Before pursuing therapeutic solutions for humans, scientists must invest in understanding the fundamental biology behind this delicate balance.

UPMC Children's Hospital of Pittsburgh

Narrative B

Heart attack survivors cannot afford to wait decades for answers about why heart muscle cells lose their ability to divide. Emerging treatments that reactivate these cells have demonstrated regenerative potential in animal studies, offering hope for future therapies. Understanding cardiac development matters, but translating these discoveries into treatments that restore damaged hearts must remain the priority.